Depression and Anxiety: Prevalence, Risk Factors and Treatment

$82.00

Shelley L. Becker (Editor)

Series: Psychiatry – Theory, Applications and Treatments
BISAC: MED105000

Depression has always been at the center stage of psychiatry, with many resources allocated to its study and treatment. Depression and Anxiety: Prevalence, Risk Factors and Treatment first reviews the emerging Integrative Evolutionary-Stress Response-Predictive Processing Framework Theory, which may offer useful insights for clinical practice.

Sexual problems and dissatisfaction with sex are commonly associated with depression. More awareness and a better understanding of this condition can lead to effective treatment and enhancement of quality of life.

Following this, the authors compare benzodiazepine use in patients with major depression and anxiety disorders to determine which demographic features are related to benzodiazepine use and constitute risk factors for benzodiazepine dependence.

Literature suggests correlations between the abnormalities in the hypothalamic–pituitary–adrenal axis and anxiety disorders, especially in terms of cortisol levels. As such, this compilation systematically assesses the available research data in the last 10 years, shedding light on the association between psychoneuroimmunology and anxiety.

The closing article uses pooled data from 1983-2008 to assess the psychophysiological measures of anxiety. Various databases were searched for articles in English using search words related to psychophysiological measures of anxiety, markers for anxiety, physiological changes anxiety, and monitors of emotional change. The implications of the findings will contribute to further research on improved management for anxiety disorders.

(Imprint: Nova Medicine and Health)

Clear

Details

Table of Contents

Preface

Chapter 1. On a Path to Integration of the Theory and Practice of Depression: Evolution, Stress, and Predictive Processing
(Valery Krupnik, Department of Mental Health, Naval Hospital Camp Pendleton, Camp Pendleton, CA, US)

Chapter 2. Sexual Dysfunction and Depression in Females
(Swaleha Mujawar, Suprakash Chaudhury and Daniel Saldanha, Department of Psychiatry, Dr. D. Y. Patil Medical College, Dr. D. Y. Patil University, Pune, Maharshtra, India, and others)

Chapter 3. A Comparative Study of the Use of Benzodiazepines among Patients with Major Depression and Anxiety Disorders
(María Yoldi-Negrete, Rebeca Robles García, Nicolás Martínez-López, Sara Martínez-Caramillo, Mariana Jimenez-Tirado, Carlos-Alfonso Tovilla-Zárate, Eduardo Madrigal and Ana Fresán, Subdirección de Investigaciones Clínicas. Instituto Nacional de Psiquiatría Ramón de la Fuente Muñíz, Ciudad de México, Mexico, and others)

Chapter 4. Immunology of Anxiety Disorders
(Suprakash Chaudhury,Satyam Kishore, Ajay K Bakhla and Swaleha Mujawar, Department of Psychiatry, Dr. D. Y. Patil Medical College, Dr. D. Y. Patil University, Pune, Maharshtra, India, and others)

Chapter 5. Psychophysiological Measures of Anxiety
(Suprakash Chaudhury, Swaleha Mujawar and Daniel Saldanha, Department of Psychiatry, Dr. D. Y. Patil Medical College, Dr. D. Y. Patil University, Pune, Maharshtra, India)

Index

Additional information

Binding

,